ArticleJCI insight2022

Intraperitoneal injection of class A TLR9 agonist enhances anti-PD-1 immunotherapy in colorectal peritoneal metastases.

Ting Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.